;PMID: 8476784
;source_file_989.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..51] = [t:0..51]
;1)sentence:[e:57..125] = [t:57..125]
;2)section:[e:129..204] = [t:129..204]
;3)section:[e:208..273] = [t:208..273]
;4)sentence:[e:277..342] = [t:277..342]
;5)sentence:[e:343..421] = [t:343..421]
;6)sentence:[e:422..517] = [t:422..517]
;7)sentence:[e:518..625] = [t:518..625]
;8)sentence:[e:626..753] = [t:626..753]
;9)sentence:[e:755..858] = [t:755..858]
;10)section:[e:862..906] = [t:862..906]

;section 0 Span:0..51
;J Steroid Biochem Mol Biol. 1993 Mar;44(4-6):681-2.
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..9] Steroid) (NNP:[10..17] Biochem)
        (NNP:[18..21] Mol) (NNP:[22..26] Biol) (.:[26..27] .) (CD:[28..32] 1993)
        (CC:[33..41] Mar;44-LRB-4) (HYPH:[41..42] -) (JJ:[42..44] 6-RRB-)
        (CD:[44..48] :681) (HYPH:[48..49] -) (CD:[49..50] 2) (.:[50..51] .)))

;sentence 1 Span:57..125
;Org 33201: a new highly selective orally active aromatase inhibitor.
;[57..66]:substance:"Org 33201"
;[105..114]:cyp450:"aromatase"
;[115..124]:substance:"inhibitor"
(SENT
  (NP-HLN
    (NP (NN:[57..60] Org) (CD:[61..66] 33201))
    (::[66..67] :)
    (NP (DT:[68..69] a) (JJ:[70..73] new)
      (ADJP (RB:[74..80] highly) (JJ:[81..90] selective))
      (ADJP (RB:[91..97] orally) (JJ:[98..104] active))
      (NN:[105..114] aromatase) (NN:[115..124] inhibitor))
    (.:[124..125] .)))

;section 2 Span:129..204
;Geelen JA, Loozen HJ, Deckers GH, de Leeuw R, Kloosterboer HJ, Lamberts SW.
(SEC
  (FRAG (NNP:[129..135] Geelen) (NNP:[136..138] JA) (,:[138..139] ,)
        (NNP:[140..146] Loozen) (NNP:[147..149] HJ) (,:[149..150] ,)
        (NNP:[151..158] Deckers) (NNP:[159..161] GH) (,:[161..162] ,)
        (IN:[163..165] de) (NNP:[166..171] Leeuw) (NNP:[172..174] R,)
        (NNP:[175..187] Kloosterboer) (NNP:[188..190] HJ) (,:[190..191] ,)
        (NNP:[192..200] Lamberts) (NNP:[201..204] SW.)))

;section 3 Span:208..273
;Scientific Development Group, Organon Int., Oss, The Netherlands.
(SEC
  (FRAG (NNP:[208..218] Scientific) (NNP:[219..230] Development)
        (NNP:[231..236] Group) (,:[236..237] ,) (NNP:[238..245] Organon)
        (NNP:[246..250] Int.) (,:[250..251] ,) (NNP:[252..255] Oss)
        (,:[255..256] ,) (DT:[257..260] The) (NNP:[261..272] Netherlands)
        (.:[272..273] .)))

;sentence 4 Span:277..342
;Org 33201 has been selected as a very potent aromatase inhibitor.
;[277..286]:substance:"Org 33201"
;[322..331]:cyp450:"aromatase"
;[332..341]:substance:"inhibitor"
(SENT
  (S
    (NP-SBJ-1 (NN:[277..280] Org) (CD:[281..286] 33201))
    (VP (VBZ:[287..290] has)
      (VP (VBN:[291..295] been)
        (VP (VBN:[296..304] selected)
          (NP-1 (-NONE-:[304..304] *))
          (PP (IN:[305..307] as)
            (NP (DT:[308..309] a)
              (ADJP (RB:[310..314] very) (JJ:[315..321] potent))
              (NN:[322..331] aromatase) (NN:[332..341] inhibitor))))))
    (.:[341..342] .)))

;sentence 5 Span:343..421
;The compound  is an enantiomer of a SC2H5 substituted
;imidazoylethylphenalene.
;[347..355]:substance:"compound"
;[363..373]:substance:"enantiomer"
;[379..384]:substance:"SC2H5"
;[397..420]:substance:"imidazoylethylphenalene"
(SENT
  (S
    (NP-SBJ (DT:[343..346] The) (NN:[347..355] compound))
    (VP (VBZ:[357..359] is)
      (NP-PRD
        (NP (DT:[360..362] an) (NN:[363..373] enantiomer))
        (PP (IN:[374..376] of)
          (NP (DT:[377..378] a)
            (ADJP (NN:[379..384] SC2H5) (VBN:[385..396] substituted))
            (NN:[397..420] imidazoylethylphenalene)))))
    (.:[420..421] .)))

;sentence 6 Span:422..517
;Org 33201  inhibited human aromatase activity for 50% at a concentration of
;2.2 x 10(9)  mol/l.
;[422..431]:substance:"Org 33201"
;[449..458]:cyp450:"aromatase"
;[472..475]:quantitative-value:"50%"
;[498..509]:quantitative-value:"2.2 x 10(9)"
;[511..516]:quantitative-units:"mol/l"
(SENT
  (S
    (NP-SBJ (NN:[422..425] Org) (CD:[426..431] 33201))
    (VP (VBD:[433..442] inhibited)
      (NP (JJ:[443..448] human) (NN:[449..458] aromatase)
          (NN:[459..467] activity))
      (PP (IN:[468..471] for)
        (NP-EXT (CD:[472..474] 50) (NN:[474..475] %)))
      (PP (IN:[476..478] at)
        (NP
          (NP (DT:[479..480] a) (NN:[481..494] concentration))
          (PP (IN:[495..497] of)
            (NP
              (NP
                (QP (CD:[498..501] 2.2) (SYM:[502..503] x)
                    (CD:[504..509] 10-LRB-9-RRB-))
                (NN:[511..514] mol))
              (PP (SYM:[514..515] /)
                (NP (NN:[515..516] l))))))))
    (.:[516..517] .)))

;sentence 7 Span:518..625
;More than 200-fold higher concentrations were needed for the inhibition  of
;other cytochrome P-450 enzymes.
;[528..536]:quantitative-value:"200-fold"
;[600..624]:cyp450:"cytochrome P-450 enzymes"
(SENT
  (S
    (NP-SBJ-1
      (ADJP
        (ADJP (RBR:[518..522] More))
        (PP (IN:[523..527] than)
          (ADJP
            (ADVP (CD:[528..531] 200) (HYPH:[531..532] -) (RB:[532..536] fold))
            (JJR:[537..543] higher))))
      (NNS:[544..558] concentrations))
    (VP (VBD:[559..563] were)
      (VP (VBN:[564..570] needed)
        (NP-1 (-NONE-:[570..570] *))
        (PP (IN:[571..574] for)
          (NP
            (NP (DT:[575..578] the) (NN:[579..589] inhibition))
            (PP (IN:[591..593] of)
              (NP (JJ:[594..599] other)
                
                (NML (NN:[600..610] cytochrome) (NN:[611..616] P-450))
                (NNS:[617..624] enzymes)))))))
    (.:[624..625] .)))

;sentence 8 Span:626..753
;In vivo the compound was active in rats (ED50  = 0.035 mg/kg) and dogs (1
;mg/kg gave 70% inhibition) after oral administration.
;[638..646]:substance:"compound"
;[667..671]:quantitative-name:"ED50"
;[675..680]:quantitative-value:"0.035"
;[681..686]:quantitative-units:"mg/kg"
;[698..699]:quantitative-value:"1"
;[700..705]:quantitative-units:"mg/kg"
;[711..714]:quantitative-value:"70%"
(SENT
  (S
    (ADVP (FW:[626..628] In) (FW:[629..633] vivo))
    (NP-SBJ (DT:[634..637] the) (NN:[638..646] compound))
    (VP (VBD:[647..650] was)
      (ADJP-PRD (JJ:[651..657] active))
      (PP-LOC (IN:[658..660] in)
        (NP
          (NP
            (NP (NNS:[661..665] rats))
            (PRN (-LRB-:[666..667] -LRB-)
              (S
                (NP-SBJ (NN:[667..671] ED50))
                (VP (SYM:[673..674] =)
                  (NP
                    (NP (CD:[675..680] 0.035) (NN:[681..683] mg))
                    (PP (SYM:[683..684] /)
                      (NP (NN:[684..686] kg))))))
              (-RRB-:[686..687] -RRB-)))
          (CC:[688..691] and)
          (NP
            (NP (NNS:[692..696] dogs))
            (PRN (-LRB-:[697..698] -LRB-)
              (S
                (NP-SBJ
                  (NP (CD:[698..699] 1) (NN:[700..702] mg))
                  (PP (SYM:[702..703] /)
                    (NP (NN:[703..705] kg))))
                (VP (VBD:[706..710] gave)
                  (NP
                    (NML-EXT (CD:[711..713] 70) (NN:[713..714] %))
                    (NN:[715..725] inhibition))))
              (-RRB-:[725..726] -RRB-)))))
      (PP-TMP (IN:[727..732] after)
        (NP (JJ:[733..737] oral) (NN:[738..752] administration))))
    (.:[752..753] .)))

;sentence 9 Span:755..858
;It can be concluded that Org 33201 is a potent and highly selective orally 
;active aromatase inhibitor.
;[780..789]:substance:"Org 33201"
;[838..847]:cyp450:"aromatase"
;[848..857]:substance:"inhibitor"
(SENT
  (S
    (NP-SBJ-1
      (NP (PRP:[755..757] It))
      (SBAR-2 (-NONE-:[757..757] *EXP*)))
    (VP (MD:[758..761] can)
      (VP (VB:[762..764] be)
        (VP (VBN:[765..774] concluded)
          (NP-1 (-NONE-:[774..774] *))
          (SBAR-2 (IN:[775..779] that)
            (S
              (NP-SBJ (NN:[780..783] Org) (CD:[784..789] 33201))
              (VP (VBZ:[790..792] is)
                (NP-PRD (DT:[793..794] a)
                  (ADJP
                    (ADJP (JJ:[795..801] potent))
                    (CC:[802..805] and)
                    (ADJP (RB:[806..812] highly) (JJ:[813..822] selective)))
                  (ADJP (RB:[823..829] orally) (JJ:[831..837] active))
                  (NN:[838..847] aromatase) (NN:[848..857] inhibitor))))))))
    (.:[857..858] .)))

;section 10 Span:862..906
;PMID: 8476784 [PubMed - indexed for MEDLINE]
(SEC
  (S (NNP:[862..866] PMID) (::[866..867] :) (CD:[868..875] 8476784)
     (IN:[876..877] -LSB-) (NNP:[877..883] PubMed) (HYPH:[884..885] -)
     (JJ:[886..893] indexed) (IN:[894..897] for) (NNP:[898..906] MEDLINE-RSB-)))
